Associated Papers
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM et al.
Saudi Journal of Biological Sciences, 2021
33424349 (PubMed )
Supplement: mmc1.xlsx › Sheet1
Targeted next generation sequencing as a tool for precision medicine.
Gulilat M et al.
Bmc Medical Genomics, 2019
31159795 (PubMed )
Supplement: 12920_2019_527_MOESM1_ESM.xlsx › Table_S6
Insights into CYP2B6-mediated drug-drug interactions.
Hedrich WD et al.
Acta Pharmaceutica Sinica. B, 2016
Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?
Singh V et al.
Cancer Investigation, 2008
Identification of CYP2B6 sequence variants by use of multiplex PCR with allele-specific genotyping.
Jacob RM et al.
Clinical Chemistry, 2004
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.
Lang T et al.
Pharmacogenetics, 2001
Select a paper to view details